Temat: "Leukemia, Myeloid" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Nilotinib-Associated Multiple Silent Arterial Stenoses in a Patient with Chronic Myeloid Leukemia
Autorzy:: Tokatlı M; Hacettepe University Faculty of Medicine, Department of Internal Medicine, Ankara, Türkiye
Ismayilov R; Hacettepe University Faculty of Medicine, Department of Internal Medicine, Ankara, Türkiye
Erkin Çınar O; Hacettepe University Faculty of Medicine, Department of Hematology, Ankara, Türkiye
Haznedaroğlu İC; Hacettepe University Faculty of Medicine, Department of Hematology, Ankara, Türkiye; Pokaż więcej
Źródło:: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 Mar 01; Vol. 41 (1), pp. 59-60. Date of Electronic Publication: 2023 Dec 28.
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/complications
Leukemia, Myeloid*/complications
Antineoplastic Agents*/adverse effects
Leukemia, Myeloid, Chronic-Phase*/complications
Humans ; Constriction, Pathologic/complications ; Pyrimidines/adverse effects ; Protein Kinase Inhibitors/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Deep learning assists in acute leukemia detection and cell classification via flow cytometry using the acute leukemia orientation tube.
Autorzy:: Cheng FM; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
Lo SC; Artificial Intelligence Center, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
Lin CC; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
Lo WJ; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
Chien SY; Artificial Intelligence Center, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
Sun TH; Artificial Intelligence Center, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan.
Hsu KC; Artificial Intelligence Center, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan. .; School of Medicine, China Medical University, Taichung, 404, Taiwan. .; Neuroscience and Brain Disease Center, China Medical University, Taichung, 404, Taiwan. .; Department of Neurology, China Medical University Hospital, China Medical University, Taichung, 404, Taiwan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 09; Vol. 14 (1), pp. 8350. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Journal Article
MeSH Terms:: Deep Learning*
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/pathology
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/pathology
Humans ; Retrospective Studies ; Flow Cytometry/methods ; Artificial Intelligence ; Acute Disease ; Immunophenotyping

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Landscape of FLT3 Variations Associated with Structural and Functional Impact on Acute Myeloid Leukemia: A Computational Study.
Autorzy:: Mirza Z; King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Al-Saedi DA; Department of Biochemistry, Faculty of Sciences, University of Tabuk, Tabuk 48322, Saudi Arabia.
Alganmi N; Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Computer Science Department, Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Karim S; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 18; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 18.
Typ publikacji:: Journal Article
MeSH Terms:: fms-Like Tyrosine Kinase 3*/genetics
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/metabolism
Humans ; Molecular Docking Simulation ; Sorafenib/pharmacology ; Mutation ; Protein-Tyrosine Kinases/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Differential Gene Regulatory Network Analysis between Azacitidine-Sensitive and -Resistant Cell Lines.
Autorzy:: Park H; School of Mathematics, Statistics and Data Science, Sungshin Women's University, Seoul 02844, Republic of Korea.
Miyano S; M&D Data Science Center, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan.; Human Genome Center, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokane-dai, Minato-ku, Tokyo 108-8639, Japan.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 14; Vol. 25 (6). Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/metabolism
Neuropeptides*/metabolism
Humans ; Azacitidine/pharmacology ; Azacitidine/therapeutic use ; Gene Regulatory Networks ; Cell Line, Tumor ; Metallothionein/genetics ; Metallothionein/metabolism ; GPI-Linked Proteins/metabolism ; RNA-Binding Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era.
Autorzy:: Iat A; Hematology department, Nice University Hospital, Nice, France.
Loschi M; Hematology department, Nice University Hospital, Nice, France.; Mediterranean Center of Molecular Medecine, INSERM, Nice, France.; Cote d'Azur University, Nice, France.
Benachour S; Hematology department, Nice University Hospital, Nice, France.
Calleja A; Hematology department, Nice University Hospital, Nice, France.
Chiche E; Hematology department, Nice University Hospital, Nice, France.; Cote d'Azur University, Nice, France.
Sudaka I; Hematology Laboratory, Nice University Hospital, Nice, France.
Aquaronne D; Hematology Laboratory, Nice University Hospital, Nice, France.
Ferrero C; Hematology Laboratory, Nice University Hospital, Nice, France.
Fenwarth L; Hematology Laboratory, Lille University Hospital, Lille, France.
Marceau A; Hematology Laboratory, Lille University Hospital, Lille, France.
Fournier E; Hematology Laboratory, Lille University Hospital, Lille, France.
Dadone-Montaudie B; Cote d'Azur University, Nice, France.; Molecular Laboratory, Nice University Hospital, Nice, France.
Cluzeau T; Hematology department, Nice University Hospital, Nice, France.; Mediterranean Center of Molecular Medecine, INSERM, Nice, France.; Cote d'Azur University, Nice, France.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (6), pp. e7103.
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Humans ; Aged ; Nucleophosmin ; Retrospective Studies ; Prognosis ; Mutation ; Risk Assessment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Venetoclax efficacy on acute myeloid leukemia is enhanced by the combination with butyrate.
Autorzy:: Kawakatsu R; Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
Tadagaki K; Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
Yamasaki K; Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
Yoshida T; Department of Biochemistry and Molecular Biology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 29; Vol. 14 (1), pp. 4975. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:: Journal Article
MeSH Terms:: Butyrates*/pharmacology
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/metabolism
Sulfonamides*
Humans ; Cell Line, Tumor ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Bridged Bicyclo Compounds, Heterocyclic/pharmacology ; Apoptosis ; Caspases

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: [Effect of venetoclax plus chemotherapy on treatment-naive acute myeloid leukemia patients with moderate to poor cytogenetic profiles and the combination's influence on the expression of proteins of the anti-apoptoic family].
Źródło:: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Feb 23; Vol. 46 (2), pp. 161-167.
Typ publikacji:: English Abstract; Journal Article; Observational Study; Randomized Controlled Trial
MeSH Terms:: Bridged Bicyclo Compounds, Heterocyclic*
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Sulfonamides*
Adult ; Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cytarabine/therapeutic use ; Cytogenetic Analysis ; Myeloid Cell Leukemia Sequence 1 Protein/therapeutic use ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Organomegalies as a predictive indicator of leukemia cutis in patients with acute myeloid leukemia.
Autorzy:: Kanitthamniyom C; Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Wannaphut C; Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, United States of America.
Pattanaprichakul P; Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Kungwankiattichi S; Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Center of Excellence of Siriraj Adult Acute Myeloid/Lymphoblastic Leukemia (SiAML), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Owattanapanich W; Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Center of Excellence of Siriraj Adult Acute Myeloid/Lymphoblastic Leukemia (SiAML), Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 16; Vol. 19 (2), pp. e0297805. Date of Electronic Publication: 2024 Feb 16 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia, Myeloid, Acute*/complications
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/pathology
Skin Neoplasms*/complications
Leukemia, Monocytic, Acute*
Female ; Humans ; Adult ; Middle Aged ; Aged ; Retrospective Studies ; Case-Control Studies ; Recurrence ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Roles of Glutathione and AP-1 in the Enhancement of Vitamin D-Induced Differentiation by Activators of the Nrf2 Signaling Pathway in Acute Myeloid Leukemia Cells.
Autorzy:: Jramne-Saleem Y; Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel.
Danilenko M; Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 14; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:: Journal Article
MeSH Terms:: Transcription Factor AP-1*/metabolism
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/metabolism
Abietanes*
Humans ; NF-E2-Related Factor 2/metabolism ; Antioxidants/pharmacology ; Vitamin D/therapeutic use ; Vitamins/pharmacology ; Receptors, Calcitriol/metabolism ; Cell Differentiation ; Signal Transduction ; Glutathione/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Minimal Residual Disease in Acute Myeloid Leukemia: Old and New Concepts.
Autorzy:: Chea M; Laboratoire d'Hématologie Biologique, Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, 31059 Toulouse, France.
Rigolot L; Laboratoire d'Hématologie Biologique, Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, 31059 Toulouse, France.; School of Medicine, Université Toulouse III Paul Sabatier, 31062 Toulouse, France.
Canali A; Laboratoire d'Hématologie Biologique, Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, 31059 Toulouse, France.; School of Medicine, Université Toulouse III Paul Sabatier, 31062 Toulouse, France.
Vergez F; Laboratoire d'Hématologie Biologique, Institut Universitaire du Cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Toulouse, 31059 Toulouse, France.; School of Medicine, Université Toulouse III Paul Sabatier, 31062 Toulouse, France.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 10; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/therapy
Hematopoietic Stem Cell Transplantation*
Humans ; Neoplasm, Residual ; Recurrence ; Flow Cytometry/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Special Issue "Advances in Molecular Pathogenesis and Targeted Therapies for Myeloid Neoplasms".
Autorzy:: Kok CH; Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide 5000, Australia.; Adelaide Medical School, University of Adelaide, Adelaide 5000, Australia.; Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide 5000, Australia.; Clinical and Health Sciences, University of South Australia, Adelaide 5000, Australia.
Yeung DT; Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide 5000, Australia.; Adelaide Medical School, University of Adelaide, Adelaide 5000, Australia.; Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide 5000, Australia.
Hiwase DK; Precision Cancer Medicine Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide 5000, Australia.; Adelaide Medical School, University of Adelaide, Adelaide 5000, Australia.; Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide 5000, Australia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 08; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:: Editorial
MeSH Terms:: Myeloproliferative Disorders*/drug therapy
Myeloproliferative Disorders*/genetics
Myelodysplastic Syndromes*/genetics
Myelodysplastic Syndromes*/therapy
Myelodysplastic Syndromes*/pathology
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/therapy
Hematologic Neoplasms*/genetics
Hematologic Neoplasms*/therapy
Humans ; Mutation

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission.
Autorzy:: Jia X; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Liao N; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Yu S; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Li H; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Liu H; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Zhang H; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Xu J; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Yao Y; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
He H; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Yu G; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Liu Q; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Zhang Y; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.
Shi P; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Clinical Medical Research Center of Hematological Diseases of Guangdong Province, Guangzhou, China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (4), pp. e7074.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/therapy
Leukemia, Myeloid, Acute*/metabolism
Adult ; Humans ; Transplantation, Homologous ; Stem Cell Transplantation ; Recurrence ; Pathologic Complete Response ; Neoplasm, Residual ; Retrospective Studies ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapy.
Autorzy:: Leroy H; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France.
Gadaud N; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Bérard E; Centre Hospitalier Universitaire de Toulouse, Service d'Epidémiologie, CERPOP, Inserm, Université Toulouse III Paul Sabatier, Toulouse, France.
Klein E; CHU Bordeaux, Laboratoire d'Hématologie Biologique, Bordeaux, France.
Luquet I; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Vial JP; CHU Bordeaux, Laboratoire d'Hématologie Biologique, Bordeaux, France.
Rieu JB; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Lechevalier N; CHU Bordeaux, Laboratoire d'Hématologie Biologique, Bordeaux, France.
Tavitian S; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Leguay T; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France.
Largeaud L; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Bidet A; CHU Bordeaux, Laboratoire d'Hématologie Biologique, Bordeaux, France.
Delabesse E; Laboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Sarry A; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
de Grande AC; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France.
Récher C; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Pigneux A; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France.; Université de Bordeaux, Bordeaux, Institut National de la Santé et de la Recherche Médicale, Bordeaux, France.
Bertoli S; Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Dumas PY; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France.; Université de Bordeaux, Bordeaux, Institut National de la Santé et de la Recherche Médicale, Bordeaux, France.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e7003.
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia, Myeloid, Acute*/complications
Leukemia, Myeloid, Acute*/drug therapy
Myelodysplastic Syndromes*/complications
Myelodysplastic Syndromes*/drug therapy
Humans ; Middle Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Azacitidine/therapeutic use ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Neurocognitive and psychosocial outcomes in survivors of childhood leukemia with Down syndrome.
Autorzy:: Gandy K; Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Department of Social Sciences, University of Houston Downtown, Houston, Texas, USA.
Hall L; Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Krull KR; Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Esbensen AJ; Division of Developmental and Behavioral Pediatrics, Cincinnati Children's Hospital Medical Center & University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Rubnitz J; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Jacola LM; Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6842. Date of Electronic Publication: 2024 Jan 19.
Typ publikacji:: Journal Article
MeSH Terms:: Down Syndrome*/complications
Leukemia, Myeloid, Acute*/complications
Leukemia, Myeloid, Acute*/epidemiology
Child ; Humans ; Male ; Child, Preschool ; Female ; Executive Function ; Survivors/psychology ; Attention

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Ablation of Wnt signaling in bone marrow stromal cells overcomes microenvironment-mediated drug resistance in acute myeloid leukemia.
Autorzy:: Palani HK; Department of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India.
Ganesan S; Department of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India.
Balasundaram N; Department of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India.
Venkatraman A; Department of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India.
Korula A; Department of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India.
Abraham A; Department of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India.
George B; Department of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India.
Mathews V; Department of Haematology, Christian Medical College, Ranipet Campus, Vellore, 632 517, India. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 10; Vol. 14 (1), pp. 8404. Date of Electronic Publication: 2024 Apr 10.
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia, Myeloid, Acute*/metabolism
Mesenchymal Stem Cells*/metabolism
Animals ; Mice ; Wnt Signaling Pathway ; Bone Marrow/metabolism ; Stromal Cells/metabolism ; Drug Resistance ; Bone Marrow Cells ; Tumor Microenvironment/physiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Data-driven modeling of core gene regulatory network underlying leukemogenesis in IDH mutant AML.
Autorzy:: Katebi A; Department of Bioengineering, Northeastern University, Boston, MA, USA.; Center for Theoretical Biological Physics, Northeastern University, Boston, MA, USA.
Chen X; Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Ramirez D; Department of Bioengineering, Northeastern University, Boston, MA, USA.; Center for Theoretical Biological Physics, Northeastern University, Boston, MA, USA.
Li S; Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. .; Department of Computer Science & Engineering, University of Connecticut, Storrs, CT, USA. .; The Jackson Laboratory Cancer Center, Bar Harbor, ME, USA. .
Lu M; Department of Bioengineering, Northeastern University, Boston, MA, USA. .; Center for Theoretical Biological Physics, Northeastern University, Boston, MA, USA. .; Pokaż więcej
Źródło:: NPJ systems biology and applications [NPJ Syst Biol Appl] 2024 Apr 09; Vol. 10 (1), pp. 38. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Journal Article
MeSH Terms:: Nucleophosmin*
Leukemia, Myeloid, Acute*/genetics
Humans ; Gene Regulatory Networks/genetics ; Isocitrate Dehydrogenase/genetics ; Carcinogenesis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: RIO-kinase 2 is essential for hematopoiesis.
Autorzy:: Messling JE; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
Peña-Rømer I; The Institute of Cancer Research, London, United Kingdom.
Moroni AS; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
Bruestl S; The Institute of Cancer Research, London, United Kingdom.
Helin K; The Institute of Cancer Research, London, United Kingdom.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Apr 02; Vol. 19 (4), pp. e0300623. Date of Electronic Publication: 2024 Apr 02 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cells*/metabolism
Leukemia, Myeloid, Acute*/metabolism
Animals ; Humans ; Mice ; Bone Marrow Transplantation ; Cell Differentiation/physiology ; Hematopoiesis/genetics ; Mice, Knockout

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia.
Autorzy:: Uechi L; Division of Mathematical Oncology and Computational Systems Biology, Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, 91010, USA.
Vasudevan S; The Institute of Biomedical and Oral Research, Faculty of Dental Medicine, The Hebrew University of Jerusalem, P.O.B. 12272, Ein Kerem, Jerusalem, 91120, Israel.
Vilenski D; The Institute of Biomedical and Oral Research, Faculty of Dental Medicine, The Hebrew University of Jerusalem, P.O.B. 12272, Ein Kerem, Jerusalem, 91120, Israel.
Branciamore S; Division of Mathematical Oncology and Computational Systems Biology, Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, 91010, USA.
Frankhouser D; Division of Mathematical Oncology and Computational Systems Biology, Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, 91010, USA.
O'Meally D; Department of Diabetes and Cancer Discovery Science, Arthur Riggs Diabetes and Metabolism Research Institute, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, 91010, USA.
Meshinchi S; Clinical Research Division, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, D5-112, Seattle, WA, 98109, USA.
Marcucci G; Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
Kuo YH; Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.
Rockne R; Division of Mathematical Oncology and Computational Systems Biology, Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, 91010, USA. .
Kravchenko-Balasha N; The Institute of Biomedical and Oral Research, Faculty of Dental Medicine, The Hebrew University of Jerusalem, P.O.B. 12272, Ein Kerem, Jerusalem, 91120, Israel. .; Pokaż więcej
Źródło:: NPJ systems biology and applications [NPJ Syst Biol Appl] 2024 Mar 25; Vol. 10 (1), pp. 32. Date of Electronic Publication: 2024 Mar 25.
Typ publikacji:: Journal Article
MeSH Terms:: Transcriptome*/genetics
Leukemia, Myeloid, Acute*/genetics
Adult ; Animals ; Mice ; Humans ; Child ; Gene Expression Profiling ; Biomarkers, Tumor/genetics ; Phenotype

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Vitamin D Mitigates Hepatic Fat Accumulation and Inflammation and Increases SIRT1/AMPK Expression in AML-12 Hepatocytes.
Autorzy:: Chang E; Department of Food and Nutrition, Gangneung-Wonju National University, Gangneung-si 25457, Gangwon State, Republic of Korea.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2024 Mar 21; Vol. 29 (6). Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Journal Article
MeSH Terms:: Non-alcoholic Fatty Liver Disease*/metabolism
Leukemia, Myeloid, Acute*/metabolism
Humans ; NLR Family, Pyrin Domain-Containing 3 Protein/metabolism ; AMP-Activated Protein Kinases/metabolism ; Sirtuin 1/genetics ; Sirtuin 1/metabolism ; Vitamin D/pharmacology ; Vitamin D/metabolism ; Hepatocytes/metabolism ; Inflammasomes/metabolism ; Inflammation/drug therapy ; Inflammation/metabolism ; Vitamins/metabolism ; Palmitic Acid/pharmacology ; Caspases/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: CLPs-miR-103a-2-5p inhibits proliferation and promotes cell apoptosis in AML cells by targeting LILRB3 and Nrf2/HO-1 axis, regulating CD8 + T cell response.
Autorzy:: Cen Q; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, People's Republic of China.
Chen J; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, People's Republic of China.
Guo J; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, People's Republic of China.
Chen M; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, People's Republic of China.
Wang H; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, People's Republic of China.
Wu S; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, People's Republic of China.
Zhang H; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, People's Republic of China. .
Xie X; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, People's Republic of China. .
Li Y; Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, People's Republic of China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2024 Mar 14; Vol. 22 (1), pp. 278. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article
MeSH Terms:: Leukemia, Myeloid, Acute*/genetics
MicroRNAs*/genetics
Animals ; Mice ; Liposomes ; NF-E2-Related Factor 2 ; Reactive Oxygen Species ; 3' Untranslated Regions/genetics ; Apoptosis/genetics ; CD8-Positive T-Lymphocytes ; Cell Proliferation/genetics ; Disease Models, Animal ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Leukemia, Myeloid"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język